Tim Boreham interviews Mike Harsh on The Health Kick Podcast
Stockhead’s resident Health and Biotech expert Tim Boreham is putting down the microscope and picking up the microphone for another installment of The Health…
Rights Commence Trading
Imagion Biosystems Limited (ASX: IBX) (the Company), is pleased to confirm that the rights associated with the Company’s Renounceable Rights Issue announced…
Appendix 4C - Quarterly
Imagion Biosystems has released its Quarterly Cashflow Report for the period ending 30 September 2019. Read Appendix 4C.
Renounceable Rights Issue — Notification to Ineligible Shareholders
Imagion Biosystems has announced a notification to ineligible shareholders regarding the renounceable pro-rata offer of 28 October 2019. Read the notification.
Renounceable Rights Issue Letter to Shareholders
Imagion Biosystems has announced a letter to shareholders regarding the 28 October 2019 announcement of a renounceable pro-rata offer. Read the letter to…
Pro-Rata Renounceable Rights Issue — Indicative Close Date
Imagion Biosystems announces an amendment to the previously announced close date. For the purposes of the Pro-Rata Renewable Rights Issue, the indicative close…
Pro-Rata Renounceable Rights Issue — Amended Timetable
Imagion Biosystems has announced and amendment to the proposed timetable for the Pro-Rata Renounceable Rights Issue as announced on Monday, 28 October 2019.…
Appendix 3B
Imagion Biosystems has announced "Appendix 3B, New issue announcement, application for quotation of additional securities and agreement." Read Appendix 3B.
Renounceable Pro-Rata Offer Prospectus
Imagion Biosystems announces a pro-rata offer prospectus. Read the pro-rata offer prospectus.
Pro-Rata Renounceable Rights Issue
Imagion Biosystems is pleased to announce a pro-rata renounceable rights issue (Offer) to fund the manufacture of the nanoparticle material, the undertaking of…